Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Pilot Study Using Metformin to Reduce Cardiac Toxicity in Breast Cancer Patients

NCT02472353 is registered in ClinicalTrials.gov with Avera McKennan Hospital & University Health Center as lead sponsor.

NCT NCT02472353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02472353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Pilot Study Using Metformin to Reduce Cardiac Toxicity in Breast Cancer Patients
Lead sponsor
Avera McKennan Hospital & University Health Center
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2014
Completion date
May 23, 2018
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast tumors